> It's not like the inefficiencies are limited to only US companies because they can charge more.
US companies cannot really charge more than European companies [+]. They all charge more in the US and less elsewhere.
[+] In general, there are also cases where the same drug is marketed by a US company in the US and a non-US company in the rest of the world.